Preoperative low skeletal muscle mass index assessed using L3-CT as a prognostic marker of clinical outcomes in pancreatic cancer patients undergoing surgery: a systematic review and meta-analysis
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: Reduction in muscle mass can be routinely quantified using computed tomography (CT) of the third lumbar vertebra (L3) during a curative pancreatic cancer (PC) course. This systematic review and meta-analysis aimed to assess the association between preoperative low skeletal muscle index (SMI) measured by L3-CT and postoperative clinical outcomes in PC resectable patients. Methods: Three electronic databases (PubMed, Web of Science, and Scopus) were searched for articles published through May 2023. Duplicate titles and abstracts, full-text screening, and data extraction were performed. A meta-analysis was performed for overall survival (OS), recurrence-free survival (RFS), postoperative pancreatic fistula (POPF), morbidity, and postoperative length of stay (P-LOS). The risk of bias was assessed. Results: A total of 2942 patients with PC from 11 studies were identified. Preoperative low SMI was found in 50.9% of PC resectable patients. Preoperative low SMI was significantly associated with adjusted OS (adjusted hazard ratio, 1.52; 95% CI 1.25–1.86, P < 0.0001). No significant associations were found between preoperative low SMI and RFS, number of POPF, significant morbidity, and P-LOS ( P >0.05). Conclusions: SMI should be evaluated in a timely manner as a predictor of OS in PC resectable patients. Studies assessing nutritional protocols for maintaining/increasing skeletal muscle mass are required to develop a personalized nutritional approach to improve clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In oncological routine care, CT examinations are often performed as part of standard staging, making L3-based SMI measurements a pragmatic surrogate marker of muscle mass [6,8].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.105906 · Cited by 11,748
Mizrahi, J. D., Surana, R., Valle, J. W., & Shroff, R. T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30974-0 · Cited by 2,559
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Gupta, D., & Lis, C. G. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-69 · Cited by 1,485 · cited 1×
“These mechanisms may increase tumour aggressiveness and lead to reduced survival [45,46] .”
BackgroundMuscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Early detection of pancreatic cancer
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482
Management of Sarcopenia: A Network Meta-Analysis of Randomized Controlled Trials
Negm, A. M., Lee, J., Hamidian, R., Jones, C. A., & Khadaroo, R. G. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2022.01.057 · Cited by 137 · cited 1×
“Indeed, exercise, especially resistance exercise, has the bene fi t of improving muscle strength and mass, which helps improve the quality of life of patients with low SMI [32,33] .”
Background
Research works printed but not linked: 41
- Leroux, 2021, Targeted therapies for pancreatic cancer: overview of current treatments and new opportunities for personalized oncology, Cancers (Basel), 13, 799, 10.3390/cancers13040799 · DOI
- Karunakaran, 2021, Surgery for pancreatic cancer: current controversies and challenges, Future Oncol, 17, 5135, 10.2217/fon-2021-0533 · DOI
- Yamada, 2017, Developing and validating an age-independent equation using multi-frequency bioelectrical impedance analysis for estimation of appendicular skeletal muscle mass and establishing a cutoff for sarcopenia, Int J Environ Res Public Health, 14, 809, 10.3390/ijerph14070809 · DOI · Paper page
- Jalal, 2021, Computed tomographic sarcopenia in pancreatic cancer: further utilization to plan patient management, J Gastrointest Cancer, 52, 1183, 10.1007/s12029-021-00672-4 · DOI
- Montano-Loza, 2014, Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation, Liver Transplantation, 20, 640, 10.1002/lt.23863 · DOI · Paper page
- Rinninella, 2021, Body composition changes in gastric cancer patients during preoperative FLOT therapy: preliminary results of an italian cohort study, Nutrients, 13, 960, 10.3390/nu13030960 · DOI
- Shea, 2017, AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both, BMJ, 358, j4008, 10.1136/bmj.j4008 · DOI · Paper page
- Prado, 2008, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol, 9, 629, 10.1016/S1470-2045(08)70153-0 · DOI · Paper page
- Bassi, 2017, The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After, Surgery, 161, 584, 10.1016/j.surg.2016.11.014 · DOI · Paper page
- Clavien, 2009, The Clavien-Dindo classification of surgical complications: five-year experience, Ann Surg, 250, 187, 10.1097/SLA.0b013e3181b13ca2 · DOI · Paper page
- Stang, 2010, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur J Epidemiol, 25, 603, 10.1007/s10654-010-9491-z · DOI · Paper page
- Parmar, 1998, Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints, Stat Med, 17, 2815, 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8 · DOI · Paper page
- Tierney, 2007, Practical methods for incorporating summary time-to-event data into meta-analysis, Trials, 8, 16, 10.1186/1745-6215-8-16 · DOI · Paper page
- Pecorelli, 2016, Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery, Br J Surg, 103, 434, 10.1002/bjs.10063 · DOI · Paper page
- Ninomiya, 2017, Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: a retrospective cohort study, Int J Surg, 39, 45, 10.1016/j.ijsu.2017.01.075 · DOI · Paper page
- Okumura, 2017, Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer, Ann Surg Oncol, 24, 3732, 10.1245/s10434-017-6077-y · DOI · Paper page
- Choi, 2018, Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer, J Cachexia Sarcopenia Muscle, 9, 326, 10.1002/jcsm.12274 · DOI · Paper page
- Sugimoto, 2018, Decreased skeletal muscle volume is a predictive factor for poorer survival in patients undergoing surgical resection for pancreatic ductal adenocarcinoma, J Gastrointest Surg, 22, 831, 10.1007/s11605-018-3695-z · DOI
- Gruber, 2019, Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma, PLoS One, 14, e0215915, 10.1371/journal.pone.0215915 · DOI
- Ryu, 2020, The effects of sarcopenia and sarcopenic obesity after pancreaticoduodenectomy in patients with pancreatic head cancer, HPB (Oxford), 22, 1782, 10.1016/j.hpb.2020.04.004 · DOI
- Rom, 2022, Sarcopenia as a predictor of survival in patients with pancreatic adenocarcinoma after pancreatectomy, Ann Surg Oncol, 29, 1553, 10.1245/s10434-021-10995-y · DOI
- Menozzi, 2023, Impact of nutritional status on postoperative outcomes in cancer patients following elective pancreatic surgery, Nutrients, 15, 1958, 10.3390/nu15081958 · DOI
- Shen, 2023, The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: a retrospective study based on a large population, Cancer Med, 12, 10438, 10.1002/cam4.5779 · DOI
- Masuda, 2023, Association of sarcopenia with a poor prognosis and decreased tumor-infiltrating CD8-positive T cells in pancreatic ductal adenocarcinoma: a retrospective analysis, Ann Surg Oncol, 30, 5776, 10.1245/s10434-023-13569-2 · DOI
- Yoon, 2021, Reference values for skeletal muscle mass at the third lumbar vertebral level measured by computed tomography in a Healthy Korean Population, Endocrinol Metab (Seoul), 36, 672, 10.3803/EnM.2021.1041 · DOI
- Thormann, 2022, Sarcopenia is an independent prognostic factor in patients with pancreatic cancer—a meta-analysis, Acad Radiol, S1076-6332, 00581
- Segal, 2017, Exercise for people with cancer: a systematic review, Curr Oncol, 24, e290, 10.3747/co.24.3619 · DOI · Paper page
- Weimann, 2017, ESPEN guideline: clinical nutrition in surgery, Clin Nutr, 36, 623, 10.1016/j.clnu.2017.02.013 · DOI · Paper page
- Ratnayake, 2018, Impact of preoperative sarcopenia on postoperative outcomes following pancreatic resection: a systematic review and meta-analysis, Pancreatology, 18, 996, 10.1016/j.pan.2018.09.011 · DOI
- Bundred, 2019, Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis, HPB, 21, 1603, 10.1016/j.hpb.2019.05.018 · DOI
- Pierobon, 2021, The prognostic value of low muscle mass in pancreatic cancer patients: a systematic review and meta-analysis, J Clin Med, 10, 3033, 10.3390/jcm10143033 · DOI
- Yang, 2018, Predictive value of preoperative sarcopenia in patients with gastric cancer: a meta-analysis and systematic review, J Gastrointest Surg, 22, 1890, 10.1007/s11605-018-3856-0 · DOI
- Xie, 2021, Preoperative computed tomography-assessed sarcopenia as a predictor of complications and long-term prognosis in patients with colorectal cancer: a systematic review and meta-analysis, Langenbeck’s Arch Surg, 406, 1775, 10.1007/s00423-021-02274-x · DOI
- Park, 2012, The effect of visceral fat mass on pancreatic fistula after pancreaticoduodenectomy, J Invest Surg, 25, 169, 10.3109/08941939.2011.616255 · DOI
- Kusafuka, 2020, Pancreas-visceral fat CT value ratio and serrated pancreatic contour are strong predictors of postoperative pancreatic fistula after pancreaticojejunostomy, BMC Surg, 20, 129, 10.1186/s12893-020-00785-w · doi:10.1186/s12893-020-00785-w
- Kim, 2017, Prevalence of muscle weakness based on different diagnostic criteria in community-dwelling older adults: a comparison of grip strength dynamometers, Geriatr Gerontol Int, 17, 2089, 10.1111/ggi.13027 · DOI
- Durham, 2009, Inflammatory burden and amino acid metabolism in cancer cachexia, Curr Opin Clin Nutr Metab Care, 12, 72
- Gianotti, 2018, Nutritional support and therapy in pancreatic surgery: a position paper of the International Study Group on Pancreatic Surgery (ISGPS), Surgery, 164, 1035, 10.1016/j.surg.2018.05.040 · DOI · Paper page
- Kagedan, 2015, Enhanced recovery after pancreatic surgery: a systematic review of the evidence, HPB (Oxford), 17, 11, 10.1111/hpb.12265 · DOI · Paper page
- Yang, 2020, Immunonutrition in patients with pancreatic cancer undergoing surgical intervention: a systematic review and meta-analysis of randomized controlled trials, Nutrients, 12, 2798, 10.3390/nu12092798 · DOI
- Graffy, 2019, Deep learning-based muscle segmentation and quantifcation at abdominal CT: application to a longitudinal adult screening cohort for sarcopenia assessment, Br J Radiol, 92, 20190237, 10.1259/bjr.20190327 · DOI
Cited by
Büntzel, S. K., Büthe, L., Sulzer, S., Büntzel, J., & Büntzel, J. (2026) · Nutrients · doi:10.3390/nu18213550
Metadata
- Authors
- Raoul, P., Cintoni, M., Coppola, A., Alfieri, S., Tortora, G., Gasbarrini, A., Mele, M. C., & Rinninella, E.
- Affiliations
- Clinical Nutrition Unit
- Department of Surgical Sciences, University of Rome La Sapienza, Rome, Italy
- Digestive Surgery Unit
- Medical Oncology Unit
- Digestive Disease Center (CEMAD), Department of Medical and Abdominal Surgery and Endocrine-Metabolic Sciences; Fondazione Policlinico Universitario A. Gemelli IRCCS
- Venue
- International Journal of Surgery
- Published
- 2023-12-11
- Volume
- 110
- Issue
- 10
- Pages
- 6126-6134
- ISSN
- 1743-9159
- Cited by
- 31
- References
- 9
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preoperative low skeletal muscle mass index assessed using L3-CT as a prognostic marker of clinical outcomes in pancreatic cancer patients undergoing surgery: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1097/js9.0000000000000989
- The paper
- Raoul, P., Cintoni, M., Coppola, A., Alfieri, S., Tortora, G., Gasbarrini, A., Mele, M. C., & Rinninella, E. (2024). Preoperative low skeletal muscle mass index assessed using L3-CT as a prognostic marker of clinical outcomes in pancreatic cancer patients undergoing surgery: a systematic review and meta-analysis. International Journal of Surgery. https://doi.org/10.1097/js9.0000000000000989
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.